clinically relevant Tmax in BE study [Regulatives / Guidelines]

posted by chak – 2007-12-26 16:30 (6760 d 22:17 ago) – Posting: # 1426
Views: 3,942

Dear All,

As per ANVISA guideline, for the bioequivalence assessment the parameters Tmax must be considered if clinically relevant. Now what does clinically relevant means? How we can know that this is clinically relevant because generally BE studies are done on healthy subjects??
Hoping for a satisfactory answer.
regards
chak

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
254 visitors (0 registered, 254 guests [including 17 identified bots]).
Forum time: 15:48 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5